The EMA Recommendations On DCT Elements In Clinical Trials
There are advantages, challenges, and future implications of decentralized approaches in clinical research. Explore the transformative potential of DCTs and the significance of EMA’s recommendations in shaping the evolution of clinical trials.
Steven Burke, PhD, Director, Strategic Site Collaboration/Patient Solutions, PPD, part of Thermo Fisher Scientific, Scotland, UK
Clare Campbell-Cooper, Global head, Digital Health & Innovation, Fortrea, UK
Sarah T’Kindt, Pharm GCP Inspector, Federal Agency for Medicines and Health Product (FAMHP), Belgium
Dawie Wessels, MD, Chief Medical Officer, Signant Health, USA
The Future of Diversity in Europe
Dive into the intricacies of what diversity means within the clinical research landscape as we explore different perspectives and practices between the United States and Europe. Hear perspectives from a panel of global industry experts who will share how to ensure your trials meet diversity, equity and inclusion (DEI) best practices on both sides of the Atlantic.
Diana Foster, PhD, Chief Executive Officer, TOTAL Diversity Clinical Trial Management, USA
Angel Akinbinu, Senior Director, Clinical Trial Diversity, Syneos Health, USA
Fiona Maini, BSc, MSc, Senior Director Global Compliance and Strategy, Medidata, (a Dassault Systemes Company), UK
Should I Join A Site Network? The How’s & Why’s
Discuss the benefits, challenges, and best practices associated with joining a site network! This session will help you navigate the site network landscape and what you need to know before joining one. Discover how to unlock your site’s potential through collaboration.
Emma Maher, Senior Director, Strategic Site Solutions, IQVIA, UK
Amardeep Heer, MB ChB, Director of Research, NHS, UK
Évelyne Mabouellet Newton, Vice President, Business Development, Europe, Velocity Clinical Research, UK
Anna Tikova, MD, PhD, MBA, Associate Professor, Country Head, Pratia, Ukraine
Get Me Out Of This Bad Escape Room: Addressing Multiple Vendors
From managing different portals to time-consuming training, working with multiple vendors can be akin to being in a never-ending escape room. Hear site challenges as we discuss ideas and best practices for managing multiple vendors. Learn how to foster collaboration, streamline processes, and enhance clinical trial operations between all industry stakeholders.
Vivienne van de Walle, MD, PhD, CPI, CMO, PT&R, The Netherlands
Agata Bloswick, PhD, Vice President, Global Head Clinical Operations Delivery, Poland, Fortrea, Poland
Roman Fishchuk, MD, MSc, CEO, Clinical Trial Units, Central City Clinical Hospital of Ivano-Frankivsk City Council, Ukraine
Ryan Jones, MBA, Co-Founder and CEO, Florence Healthcare, USA
Tackling Inflation Correction & Unexpected Costs
We are in a complex landscape of inflation correction and rising unexpected costs. Through management and mitigation, sites can gain greater transparency and efficiency in clinical trial budgeting and financial management. Join this session to understand how to manage and reduce costs and adjust your budgets to account for rising costs.
David Vulcano, LCSW, MBA, CIP, RAC, Honorary President, Vice President, Clinical Research Compliance & Integrity. SCRS, HCA Healthcare, USA
Dora Csabai, Associate Director, Trial Capabilities, Lilly, Ireland
Marcin Gondek, Chief Financial Officer, FutureMeds, UK
Troy Hamilton, Director of Operations, CARe Clinic, Canada